[Paraneoplastic neurologic degeneration revealing ovarian cancer recurrence]

Pan Afr Med J. 2019 Aug 2:33:281. doi: 10.11604/pamj.2019.33.281.17711. eCollection 2019.
[Article in French]

Abstract

Paraneoplastic neurologic degeneration (PND) is characterized by acute and subacute onset neurological syndrome associated with active or with subclinical cancer. It is rare but early diagnosis can improve the neurological and carcinological prognosis. Among the PNDs it is possible to distinguish subacute cerebellar degeneration often associated with gynecological or breast cancer. We report the case of a 50-year old female patient on follow-up for ovarian adenocarcinoma treated with surgery and whose recurrence was detected due to anti-Yo antibody-positive subacute cerebellar degeneration.

Le syndrome neurologique paranéoplasique (SNP) est caractérisé par l'apparition aigue et subaigue d'un syndrome neurologique associé à un cancer actif ou infraclinique. C'est une manifestation rare dont le diagnostic précoce modifie le pronostic neurologique et carcinologique. Parmi les SNP on distingue la dégénérescence cérébelleuse subaiguë souvent associée à un cancer gynécologique ou mammaire. Nous rapportons le cas d'une patiente de 50 ans suivie pour un adénocarcinome d'ovaire opéré et dont la récidive s'est révélée par une dégénérescence cérébelleuse subaiguë avec des AC anti Yo positifs.

Keywords: Subacute cerebellar degeneration; onconeural antibodies; paraneoplastic neurologic degeneration.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / diagnosis*
  • Adenocarcinoma / pathology
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Nerve Tissue Proteins / immunology
  • Ovarian Neoplasms / diagnosis*
  • Ovarian Neoplasms / pathology
  • Paraneoplastic Cerebellar Degeneration / diagnosis*
  • Paraneoplastic Cerebellar Degeneration / immunology
  • Prognosis

Substances

  • CDR2 protein, human
  • Nerve Tissue Proteins